102 related articles for article (PubMed ID: 23692495)
21. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
22. A comparison of methods for modeling quantitative structure-activity relationships.
Sutherland JJ; O'Brien LA; Weaver DF
J Med Chem; 2004 Oct; 47(22):5541-54. PubMed ID: 15481990
[TBL] [Abstract][Full Text] [Related]
23. Elucidating inhibitory models of the inhibitors of epidermal growth factor receptor by docking and 3D-QSAR.
Chen G; Luo X; Zhu W; Luo C; Liu H; Puah CM; Chen K; Jiang H
Bioorg Med Chem; 2004 May; 12(9):2409-17. PubMed ID: 15080937
[TBL] [Abstract][Full Text] [Related]
24. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
Bhongade BA; Gouripur VV; Gadad AK
Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
[TBL] [Abstract][Full Text] [Related]
25. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Kamath S; Buolamwini JK
J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
[TBL] [Abstract][Full Text] [Related]
26. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor.
Chitta A; Jatavath MB; Fatima S; Manga V
J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569
[TBL] [Abstract][Full Text] [Related]
27. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
28. 3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues.
Juvale DC; Kulkarni VV; Deokar HS; Wagh NK; Padhye SB; Kulkarni VM
Org Biomol Chem; 2006 Aug; 4(15):2858-68. PubMed ID: 16855733
[TBL] [Abstract][Full Text] [Related]
29. 3-D QSAR studies on histone deacetylase inhibitors. A GOLPE/GRID approach on different series of compounds.
Ragno R; Simeoni S; Valente S; Massa S; Mai A
J Chem Inf Model; 2006; 46(3):1420-30. PubMed ID: 16711762
[TBL] [Abstract][Full Text] [Related]
30. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
31. 3D-QSAR studies of farnesyltransferase inhibitors: a comparative molecular field analysis approach.
Puntambekar D; Giridhar R; Yadav MR
Bioorg Med Chem Lett; 2006 Apr; 16(7):1821-7. PubMed ID: 16455255
[TBL] [Abstract][Full Text] [Related]
32. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG
Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874
[TBL] [Abstract][Full Text] [Related]
33. 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3.
Potshangbam AM; Tanneeru K; Reddy BM; Guruprasad L
Bioorg Med Chem Lett; 2011 Dec; 21(23):7219-23. PubMed ID: 22018459
[TBL] [Abstract][Full Text] [Related]
34. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
Peng T; Pei J; Zhou J
J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
[TBL] [Abstract][Full Text] [Related]
35. CoRILISA: a local similarity based receptor dependent QSAR method.
Khedkar VM; Coutinho EC
J Chem Inf Model; 2015 Jan; 55(1):194-205. PubMed ID: 25535645
[TBL] [Abstract][Full Text] [Related]
36. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
37. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
[TBL] [Abstract][Full Text] [Related]
38. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
[TBL] [Abstract][Full Text] [Related]
39. Using DFT methodology for more reliable predictive models: Design of inhibitors of Golgi α-Mannosidase II.
Bobovská A; Tvaroška I; Kóňa J
J Mol Graph Model; 2016 May; 66():47-57. PubMed ID: 27035259
[TBL] [Abstract][Full Text] [Related]
40. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods.
Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ
Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]